Global Implantable Drug-Eluting Devices Market Status and Forecast 2021-2027

Table of Contents

1 Product Introduction and Overview

• 1.1 Product Definition
• 1.2 Product Specification
• 1.3 Global Market Overview
  • 1.3.1 Global Implantable Drug-Eluting Devices Market Status and Forecast (2016-2027)
  • 1.3.2 Global Implantable Drug-Eluting Devices Sales Value CAGR by Region
• 1.4 Market Drivers, Inhibitors
  • 1.4.1 Market Drivers
  • 1.4.2 Market Inhibitors
  • 1.4.3 COVID-19 Impact Analysis

2 Global Implantable Drug-Eluting Devices Supply by Company

• 2.1 Global Implantable Drug-Eluting Devices Sales Volume by Company
• 2.2 Global Implantable Drug-Eluting Devices Sales Value by Company
• 2.3 Global Implantable Drug-Eluting Devices Price by Company
• 2.4 Implantable Drug-Eluting Devices Production Location and Sales Area of Main Manufacturers
• 2.5 Trend of Concentration Rate

3 Global and Regional Implantable Drug-Eluting Devices Market Status by Type

• 3.1 Implantable Drug-Eluting Devices Type Introduction
  • 3.1.1 Implantable Drug Infusion Pumps
  • 3.1.2 Intraocular Drug-Eluting Devices
  • 3.1.3 Contraceptive Drug-Eluting Devices
  • 3.1.4 Drug-Eluting Stents
  • 3.1.5 Others
• 3.2 Global Implantable Drug-Eluting Devices Market by Type
  • 3.2.1 Global Implantable Drug-Eluting Devices Sales Volume by Type (2016-2021)
  • 3.2.2 Global Implantable Drug-Eluting Devices Sales Value by Type (2016-2021)
  • 3.2.3 Global Implantable Drug-Eluting Devices Price by Type (2016-2021)
• 3.3 North America: by Type
• 3.4 Europe: by Type
• 3.5 Asia Pacific: by Type
• 3.6 Central & South America: by Type
• 3.7 Middle East & Africa: by Type

4 Global and Regional Implantable Drug-Eluting Devices Market Status by Application

• 4.1 Implantable Drug-Eluting Devices Segment by Application
  • 4.1.1 Diabetes
  • 4.1.2 Contraception
  • 4.1.3 HIV/AIDS Prevention
  • 4.1.4 Chronic Pain Management
  • 4.1.5 Cardiovascular
  • 4.1.6 Ophthalmology
  • 4.1.7 Oncology
  • 4.1.8 Others
• 4.2 Global Implantable Drug-Eluting Devices Market by Application
  • 4.2.1 Global Implantable Drug-Eluting Devices Sales Volume by Application (2016-2021)
  • 4.2.2 Global Implantable Drug-Eluting Devices Sales Value by Application (2016-2021)
  • 4.2.3 Global Implantable Drug-Eluting Devices Price by Application (2016-2021)
• 4.3 North America: by Application
• 4.4 Europe: by Application
• 4.5 Asia Pacific: by Application
• 4.6 Central & South America: by Application
• 4.7 Middle East & Africa: by Application

5 Global Implantable Drug-Eluting Devices Market Status by Region

• 5.1 Global Implantable Drug-Eluting Devices Market by Region
  • 5.1.1 Global Implantable Drug-Eluting Devices Sales Volume by Region
  • 5.1.2 Global Implantable Drug-Eluting Devices Sales Value by Region
• 5.2 North America Implantable Drug-Eluting Devices Market Status
• 5.3 Europe Implantable Drug-Eluting Devices Market Status
• 5.4 Asia Pacific Implantable Drug-Eluting Devices Market Status
• 5.5 Central & South America Implantable Drug-Eluting Devices Market Status
• 5.6 Middle East & Africa Implantable Drug-Eluting Devices Market Status

6 North America Implantable Drug-Eluting Devices Market Status

• 6.1 North America Implantable Drug-Eluting Devices Market by Country
  • 6.1.1 North America Implantable Drug-Eluting Devices Sales Volume by Country (2016-2021)
  • 6.1.2 North America Implantable Drug-Eluting Devices Sales Value by Country (2016-2021)
• 6.2 United States
• 6.3 Canada
• 6.4 Mexico

7 Europe Implantable Drug-Eluting Devices Market Status

• 7.1 Europe Implantable Drug-Eluting Devices Market by Country
  • 7.1.1 Europe Implantable Drug-Eluting Devices Sales Volume by Country (2016-2021)
  • 7.1.2 Europe Implantable Drug-Eluting Devices Sales Value by Country (2016-2021)
• 7.2 Germany
• 7.3 France
• 7.4 UK
• 7.5 Italy
• 7.6 Russia
• 7.7 Spain

8 Asia Pacific Implantable Drug-Eluting Devices Market Status

• 8.1 Asia Pacific Implantable Drug-Eluting Devices Market by Country
  • 8.1.1 Asia Pacific Implantable Drug-Eluting Devices Sales Volume by Country (2016-2021)
  • 8.1.2 Asia Pacific Implantable Drug-Eluting Devices Sales Value by Country (2016-2021)
• 8.2 China
• 8.3 Japan
• 8.4 Korea
• 8.5 Southeast Asia
• 8.6 India
• 8.7 Australasia

9 Central & South America Implantable Drug-Eluting Devices Market Status

• 9.1 Central & South America Implantable Drug-Eluting Devices Market by Country
  • 9.1.1 Central & South America Implantable Drug-Eluting Devices Sales Volume by Country (2016-2021)
  • 9.1.2 Central & South America Implantable Drug-Eluting Devices Sales Value by Country (2016-2021)
• 9.2 Brazil
• 9.3 Argentina
• 9.4 Colombia

10 Middle East & Africa Implantable Drug-Eluting Devices Market Status

• 10.1 Middle East & Africa Implantable Drug-Eluting Devices Market by Country
  • 10.1.1 Middle East & Africa Implantable Drug-Eluting Devices Sales Volume by Country (2016-2021)
  • 10.1.2 Middle East & Africa Implantable Drug-Eluting Devices Sales Value by Country (2016-2021)
• 10.2 Iran
• 10.3 Israel
• 10.4 Turkey
• 10.5 South Africa
• 10.8 Saudi Arabia

11 Supply Chain and Manufacturing Cost Analysis

• 11.1 Supply Chain Analysis
• 11.2 Production Process Chart Analysis
• 11.3 Raw Materials and Key Suppliers Analysis
  • 11.3.1 Raw Materials Introduction
  • 11.3.2 Raw Materials Key Suppliers List
• 11.4 Implantable Drug-Eluting Devices Manufacturing Cost Analysis
• 11.5 Implantable Drug-Eluting Devices Sales Channel and Distributors Analysis
  • 11.5.1 Implantable Drug-Eluting Devices Sales Channel
  • 11.5.2 Implantable Drug-Eluting Devices Distributors
• 11.6 Implantable Drug-Eluting Devices Downstream Major Buyers

12 Global Implantable Drug-Eluting Devices Market Forecast by Type and by Application

• 12.1 Global Implantable Drug-Eluting Devices Sales Volume and Sales Value Forecast (2022-2027)
• 12.2 Global Implantable Drug-Eluting Devices Forecast by Type
  • 12.2.1 Global Implantable Drug-Eluting Devices Sales Volume Forecast by Type
  • 12.2.2 Global Implantable Drug-Eluting Devices Sales Value Forecast by Type
  • 12.2.3 Global Implantable Drug-Eluting Devices Price Forecast by Type
• 12.3 Global Implantable Drug-Eluting Devices Forecast by Application
  • 12.3.1 Global Implantable Drug-Eluting Devices Sales Volume Forecast by Application
  • 12.3.2 Global Implantable Drug-Eluting Devices Sales Value Forecast by Application
  • 12.3.3 Global Implantable Drug-Eluting Devices Price Forecast by Application

13 Global Implantable Drug-Eluting Devices Market Forecast by Region/Country

• 13.1 Global Implantable Drug-Eluting Devices Market Forecast by Region (2022-2027)
  • 13.1.1 Global Implantable Drug-Eluting Devices Sales Volume Forecast by Region (2022-2027)
  • 13.1.2 Global Implantable Drug-Eluting Devices Sales Value Forecast by Region (2022-2027)
• 13.2 North America Market Forecast
• 13.3 Europe Market Forecast
• 13.4 Asia Pacific Market Forecast
• 13.5 Central & South America Market Forecast
• 13.6 Middle East & Africa Market Forecast

14 Key Participants Company Information

• 14.1 Titan Pharmaceuticals, Inc.
  • 14.1.1 Company Information
  • 14.1.2 Implantable Drug-Eluting Devices Product Introduction
  • 14.1.3 Titan Pharmaceuticals, Inc. Implantable Drug-Eluting Devices Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
  • 14.1.4 SWOT Analysis
• 14.2 Surmodics
  • 14.2.1 Company Information
  • 14.2.2 Implantable Drug-Eluting Devices Product Introduction
  • 14.2.3 Surmodics Implantable Drug-Eluting Devices Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
  • 14.2.4 SWOT Analysis
• 14.3 REVA Medical
  • 14.3.1 Company Information
  • 14.3.2 Implantable Drug-Eluting Devices Product Introduction
  • 14.3.3 REVA Medical Implantable Drug-Eluting Devices Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
  • 14.3.4 SWOT Analysis
• 14.4 Pfizer
  • 14.4.1 Company Information
  • 14.4.2 Implantable Drug-Eluting Devices Product Introduction
  • 14.4.3 Pfizer Implantable Drug-Eluting Devices Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
  • 14.4.4 SWOT Analysis
• 14.5 MicroPort Medical
  • 14.5.1 Company Information
  • 14.5.2 Implantable Drug-Eluting Devices Product Introduction
  • 14.5.3 MicroPort Medical Implantable Drug-Eluting Devices Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
  • 14.5.4 SWOT Analysis
• 14.6 Merck
  • 14.6.1 Company Information
  • 14.6.2 Implantable Drug-Eluting Devices Product Introduction
  • 14.6.3 Merck Implantable Drug-Eluting Devices Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
  • 14.6.4 SWOT Analysis
• 14.7 Medtronic
  • 14.7.1 Company Information
  • 14.7.2 Implantable Drug-Eluting Devices Product Introduction
  • 14.7.3 Medtronic Implantable Drug-Eluting Devices Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
  • 14.7.4 SWOT Analysis
• 14.8 Johnson & Johnson
  • 14.8.1 Company Information
  • 14.8.2 Implantable Drug-Eluting Devices Product Introduction
  • 14.8.3 Johnson & Johnson Implantable Drug-Eluting Devices Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
  • 14.8.4 SWOT Analysis
• 14.9 Boston Scientific Corporation
  • 14.9.1 Company Information
  • 14.9.2 Implantable Drug-Eluting Devices Product Introduction
  • 14.9.3 Boston Scientific Corporation Implantable Drug-Eluting Devices Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
  • 14.9.4 SWOT Analysis
• 14.10 BIOTRONIK
  • 14.10.1 Company Information
  • 14.10.2 Implantable Drug-Eluting Devices Product Introduction
  • 14.10.3 BIOTRONIK Implantable Drug-Eluting Devices Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
  • 14.10.4 SWOT Analysis
• 14.11 Bayer AG
• 14.12 Bausch & Lomb
• 14.13 Allergan
• 14.14 Abbott

15 Conclusion

16 Methodology